WALTHAM, Mass., Nov. 25, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq: TSRO ) announced today that Mary Lynne Hedley, Ph.D., President and COO of TESARO, will present at the 2014 Deutsche Bank BioFEST Conference on Tuesday, December 2, 2014 at 4:00 p.m. ET in Boston.
A live webcast will be accessible via the Investors page of the TESARO website at www.tesarobio.com . An archived replay of this webcast will be available on the Company's website for 14 days after the conference.
About TESARO
TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.
For additional information, please contact: Jennifer Davis Sr. Director, Corporate Development & Investor Relations 1.781.325.1116